Cargando…

Contribution of Metabolomics to the Understanding of NAFLD and NASH Syndromes: A Systematic Review

Several differential panels of metabolites have been associated with the presence of metabolic syndrome and its related conditions, namely non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). This study aimed to perform a systematic review to summarize the most recent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piras, Cristina, Noto, Antonio, Ibba, Luciano, Deidda, Martino, Fanos, Vassilios, Muntoni, Sandro, Leoni, Vera Piera, Atzori, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541039/ https://www.ncbi.nlm.nih.gov/pubmed/34677409 http://dx.doi.org/10.3390/metabo11100694

Ejemplares similares

Metabolomics and psychological features in fibromyalgia and electromagnetic sensitivity
por: Piras, Cristina, et al.
Publicado: (2020)

Metabolomics analysis of plasma samples of patients with fibromyalgia and electromagnetic sensitivity using GC–MS technique
por: Piras, Cristina, et al.
Publicado: (2022)

Metabolomics in Otorhinolaryngology
por: Noto, Antonio, et al.
Publicado: (2022)

Alterations of the Intestinal Permeability are Reflected by Changes in the Urine Metabolome of Young Autistic Children: Preliminary Results
por: Piras, Cristina, et al.
Publicado: (2022)

Metabolomics and Microbiomics: New Potential Strategies in Chronic Pain Syndrome
por: Piras, Cristina, et al.
Publicado: (2022)

Pediatric Acute-onset Neuropsychiatric Syndrome and Mycoplasma Pneumoniae Infection: A Case Report Analysis with a Metabolomics Approach
por: Piras, Cristina, et al.
Publicado: (2020)

Sardinian Infants of Diabetic Mothers: A Metabolomics Observational Study
por: Dessì, Angelica, et al.
Publicado: (2023)

Right Ventricular Subclinical Dysfunction in SLE Patients Correlates with Metabolomic Fingerprint and Organ Damage
por: Deidda, Martino, et al.
Publicado: (2023)

Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine
por: Pintus, Roberta, et al.
Publicado: (2017)

Metabolomics Application in Maternal-Fetal Medicine
por: Fanos, Vassilios, et al.
Publicado: (2013)

Metabolomic approach to profile functional and metabolic changes in heart failure
por: Deidda, Martino, et al.
Publicado: (2015)

Natural History of NAFLD/NASH
por: Ekstedt, Mattias, et al.
Publicado: (2017)

The role of the microbiome in NAFLD and NASH
por: Kolodziejczyk, Aleksandra A, et al.
Publicado: (2018)

Noninvasive Diagnosis of NAFLD and NASH
por: Piazzolla, Valeria Annarita, et al.
Publicado: (2020)

NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations
por: Adinolfi, Luigi Elio, et al.
Publicado: (2016)

Perinatal Asphyxia: A Review from a Metabolomics Perspective
por: Fattuoni, Claudia, et al.
Publicado: (2015)

Imaging biomarkers of NAFLD, NASH, and fibrosis
por: Ajmera, Veeral, et al.
Publicado: (2021)

Evolving Role for Pharmacotherapy in NAFLD/NASH
por: Attia, Suzanna L., et al.
Publicado: (2020)

Urinary (1)H-NMR Metabolomics in the First Week of Life Can Anticipate BPD Diagnosis
por: Pintus, Maria Cristina, et al.
Publicado: (2018)

Current and future pharmacological therapies for NAFLD/NASH
por: Sumida, Yoshio, et al.
Publicado: (2017)

Lifestyle modification in NAFLD/NASH: Facts and figures
por: Hallsworth, Kate, et al.
Publicado: (2019)

Diet and exercise in NAFLD/NASH: Beyond the obvious
por: Semmler, Georg, et al.
Publicado: (2021)

Metabolomics in Adult and Pediatric Nephrology
por: Fanos, Vassilios, et al.
Publicado: (2013)

Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH
por: Wan, Xingyong, et al.
Publicado: (2016)

Depression and Cognitive Impairment—Extrahepatic Manifestations of NAFLD and NASH
por: Colognesi, Martina, et al.
Publicado: (2020)

Current Options and Future Directions for NAFLD and NASH Treatment
por: Zhang, Chunye, et al.
Publicado: (2021)

Improved pathology reporting in NAFLD/NASH for clinical trials
por: Langford, Caitlin Rose, et al.
Publicado: (2022)

Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH
por: Welch, Ryan D., et al.
Publicado: (2022)

Nuclear hormone and peptide hormone therapeutics for NAFLD and NASH
por: Finan, Brian, et al.
Publicado: (2020)

Deciphering the role of aberrant DNA methylation in NAFLD and NASH()
por: Vachher, Meenakshi, et al.
Publicado: (2022)

Early Urinary Metabolomics in Patent Ductus Arteriosus Anticipates the Fate: Preliminary Data
por: Bardanzellu, Flaminia, et al.
Publicado: (2020)

The Echocardiographic Parameters of Systolic Function Are Associated with Specific Metabolomic Fingerprints in Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy
por: Deidda, Martino, et al.
Publicado: (2021)

Both Elafibranor and Liraglutide Improve NAFLD / NASH but Affect Differentially the Hepatic Lipidome and Metabolome in a Diet-Induced Obese and Biopsy-Confirmed Mouse Model of NASH
por: Perakakis, Nikolaos, et al.
Publicado: (2021)

Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease
por: Deidda, Martino, et al.
Publicado: (2017)

Glutamine Starvation Affects Cell Cycle, Oxidative Homeostasis and Metabolism in Colorectal Cancer Cells
por: Spada, Martina, et al.
Publicado: (2023)

Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
por: Bazick, Jessica, et al.
Publicado: (2015)

Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state
por: Deidda, Martino, et al.
Publicado: (2019)

Metabolomics Analysis of Amniotic Fluid in Euploid Foetuses with Thickened Nuchal Translucency by Gas Chromatography-Mass Spectrometry
por: Murgia, Federica, et al.
Publicado: (2021)

Liver Protective Effect of Fenofibrate in NASH/NAFLD Animal Models
por: Mahmoudi, Ali, et al.
Publicado: (2022)

Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions
por: Xu, Gao-Xin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e8c3a5q804bp0r1fpo552f5qtt